Zhifang Liu

Hangzhou Medical College

H指数:20

被引数:1,141

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Minimally Invasive Electro Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy via Right Infra-Axillary Incision

经右腋下小切口微创室间隔心肌切开术治疗肥厚型梗阻性心肌病

The Annals of Thoracic Surgery

IF0

2025-10-170

PRE

Enhanced dewatering of Jilangde flotation clean coal via composite filter aids: the influence of chemical structure on dewatering performance

通过复合滤助剂对Jilangde浮选精煤进行强化脱水：化学结构对脱水性能的影响

INTERNATIONAL JOURNAL OF COAL PREPARATION AND UTILIZATION

IF2.1

2025-09-010

PRE

Multiscale concurrent topology optimization and response of sandwich beams under low velocity impact loading

多尺度协同拓扑优化及低速冲击载荷下夹层梁的响应

Engineering Structures

IF6.4

2025-07-260

PRE

Grapefruit Extracellular-Vesicle-Derived Nanodrug Loading Three-Functional Platinum(IV) Conjugates with Enhanced Targeting and TME Modulating Properties

葡萄柚外泌体衍生的纳米药物负载三功能铂(IV)共轭物，具有增强的靶向性和TME调节特性

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-05-260

PRE

Autophagy-targeted Pt(iv) agents: a new horizon in antitumor drug development

DALTON TRANSACTIONS

IF3.3

2025-01-010

PRE

Assessment of multidimensional diversity and conservation of threatened timber trees in China under climate change

气候变化下中国受威胁用材林多维多样性评估与保护

BIOLOGICAL CONSERVATION

IF4.4

2024-12-010

PRE

Transcriptional Analysis of Different Cultivars and Genome-Wide Identification of FAD Gene Family in Tree Peony

AGRONOMY-BASEL

IF3.4

2024-10-150

Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-182

PRE

Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial-Mesenchymal Transition Suppression, and Immune Activation Properties

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-051

PRE

Role of LECT2 in exacerbating atopic dermatitis: insight from in vivo and in vitro models via NF-κB signaling pathway

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-140

OAAI

Mitral Geometry on the Mechanism of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

IF6

2024-08-011

OAAI

Canadine Platinum(IV) Complexes Targeting Epithelial-Mesenchymal Transition as Antiproliferative and Antimetastatic Agents

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-07-291

PRE

Exogenous drug-induced mouse models of atopic dermatitis

外源性药物诱导的特应性皮炎小鼠模型

CYTOKINE & GROWTH FACTOR REVIEWS

IF11.8

2024-06-012

PRE

Pre-clinical evaluation of a novel antibody drug conjugate (ADC) LM-317 targeting NaPi2b

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-01-1710

PRE

Excellent Short-Term Outcomes Achieved With Minimally Invasive Right Infra-Axillary Incision and Transaortic Modified Morrow Procedure

CIRCULATION

IF38.6

2023-11-070

PRE

Fecal microbiota transplantation affects the recovery of AD-skin lesions and enhances gut microbiota homeostasis

粪菌移植影响AD皮损恢复并增强肠道菌群稳态

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-05-0116

OAAI

Pre-clinical evaluation of a novel antibody drug conjugate (ADC) LM-306 targeting IL-13Rα2 in immuno-oncology

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Development of Clioquinol Platinum(IV) Conjugates as Autophagy- Targeted Antimetastatic Agents

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-02-2218

PRE

Multi-specific niflumic acid platinum(iv) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage

DALTON TRANSACTIONS

IF3.3

2023-01-0117

PRE

Zhifang Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向